You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. N/A

    SBC: FLYING BRIDGE TECHNOLOGIES            Topic: N/A

    N/A

    STTR Phase I 2000 Department of Health and Human ServicesNational Institutes of Health
  2. N/A

    SBC: TRIANGLE LABORATORIES, INC.            Topic: N/A

    N/A

    STTR Phase I 2000 Department of Health and Human ServicesNational Institutes of Health
  3. NON-NATURAL AMINO ACIDS IN PEPTIDE DRUG DEVELOPMENT

    SBC: ARGOLYN BIOSCIENCE, INC.            Topic: N/A

    Argolyn Bioscience Inc. is an early stage biotechnology company that creates novel peptide drugs and diagnostics with greatly improved intrinsic pharmaceutical properties through substitution of non-natural amino acid analogues for arginine (Arg) or lysine (Lys). In proof-of concept studies thus far, application of the Argolyn technology to peptides of therapeutic interest has resulted in dramatic ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  4. NOVEL NEUROTENSIN ANALOGS AS ANTISCHIZOPRENICS

    SBC: ARGOLYN BIOSCIENCE, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The brain peptide neurotensin (NT) and its active derivative NT [8-13] function as endogenous neuroleptics. Stable NT derivatives that cross the blood brain barrier therefore have significant potential for development as a new class of non-dopamineric antipsychotics expected not to display the adverse side effects associated with the dopaminergics. The best lit ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  5. DEVELOPMENT OF A NEW TREATMENT OF URINARY STONE DISEASE

    SBC: BIOSTRATUM, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Development of a new method for prophylaxis and treatment of urinary stone disease is proposed. Since a majority of urinary stones are made of calcium oxalate, the level of urinary oxalate is one of the major risk factors of stone formation. Unfortunately, there is no effective pharmacological treatment of stone disease that targets urinary oxalate concentratio ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  6. ANAEROBIC MOBILIZATION TECHNOLOGY FOR SOIL REMEDIATION

    SBC: CHATHAM RESEARCH, LTD            Topic: N/A

    DESCRIPTION (provided by applicant): A major contamination issue at over 8,000 sites in the United States are PAHs. This contamination results from almost all combustion processes, creosote treatment of wood, former town gas sites, and many others. Many of these chemicals are both toxic and carcinogenic. It has been observed that these highly hydrophobic chemicals bind tightly to soil by a numb ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  7. A NOVEL DRUG FOR ASTHMA WITH DUAL ACTION VIA AL ARS

    SBC: ENDACEA, INC            Topic: N/A

    The incidence of asthma has more thandoubled from 6.7 million in 1980 to 17.3 million in 1998 in the U.S., including 4.3 million children. Current therapies for asthma have serious side effects. Airway adenosine levels are increased in patients with asthma. Activation of A1 adenosine receptors produces bronchoconstriction, airway edema, and acute inflammation, leading to airflow obstruction. Endac ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  8. ENHANCED THERMAL TRANSFER DEVICE FOR BIOPRESERVATION

    SBC: ORGAN RECOVERY SYSTEMS, INC.            Topic: N/A

    Effective methods of preserving cells and tissues are essential for the established and emerging companies using cryopreservation as part of their production processes. Conventional freezing and thawing devices have low heat transfer efficiencies that cause non-uniform thermal processing in biological materials resulting in products with low and inconsistent cell viability. The development of an a ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  9. AUTOMATED SYNTHESIS OF F-18 FLUOROCHOLINE

    SBC: TRACERA, LLC            Topic: N/A

    Improved imaging technologies are critically needed for noninvasive detection of cancer. We have recently shown excellent imaging feasibility of prostate cancer, breast cancer and brain tumors using F-1 8 labeled choline (FCH) and positron emission tomography (PET). In order to minimize radiation exposure to radiochemistry personnel and increase th; reliability of radiotracer synthesis, it is prop ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  10. ULTRASENSITIVE METHODS FOR HUMAN BIOMARKER QUANTITATION

    SBC: TRIANGLE LABORATORIES, INC.            Topic: N/A

    Basic research aimed at understanding the complex regulations and interactions lead to various diseases requires novel bioanalytical approaches that allow detailed characterization of the proteome with ultra high-speed and sensitivity so that important regulatory proteins can be effectively studied. For the analysis of complex protein mixtures such as cell lysates, two-dimensional polyacrylamide g ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government